127 related articles for article (PubMed ID: 2159701)
21. What we know about anti-HIV drugs.
Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
[TBL] [Abstract][Full Text] [Related]
22. Association between zalcitabine therapy for human immunodeficiency virus and granuloma annulare?
Peñas PF; Jones-Caballero M; García-Díez A
Arch Dermatol; 2001 Jul; 137(7):964. PubMed ID: 11453824
[No Abstract] [Full Text] [Related]
23. Dideoxycytidine: current clinical experience and future prospects. A summary.
Broder S; Yarchoan R
Am J Med; 1990 May; 88(5B):31S-33S. PubMed ID: 2159708
[TBL] [Abstract][Full Text] [Related]
24. Finding a role for zalcitabine in the HAART era.
Moyle GJ; Gazzard BG
Antivir Ther; 1998; 3(3):125-37. PubMed ID: 10682130
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of zidovudine and zalcitabine combined with a combination of herbs in the treatment of HIV-infected Thai patients.
Sangkitporn S; Shide L; Klinbuayaem V; Leenasirimakul P; Wirayutwatthana NA; Leechanachai P; Dettrairat S; Kunachiwa W; Thamlikitkul V
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):704-8. PubMed ID: 16124442
[TBL] [Abstract][Full Text] [Related]
26. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
27. Zalcitabine.
Shelton MJ; O'Donnell AM; Morse GD
Ann Pharmacother; 1993 Apr; 27(4):480-9. PubMed ID: 8097417
[TBL] [Abstract][Full Text] [Related]
28. [Treatments of human immunodeficiency virus infection. Current developments].
Sereni D; Rousseau F
Ann Med Interne (Paris); 1991; 142(3):209-14. PubMed ID: 1649566
[No Abstract] [Full Text] [Related]
29. Theoretical mechanistic basis of the toxic effects and efficacy of dideoxycytidine in HIV:AIDS.
Akintonwa DA
Med Hypotheses; 2001 Aug; 57(2):249-51. PubMed ID: 11461183
[TBL] [Abstract][Full Text] [Related]
30. Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations.
Izopet J; Sailler L; Sandres K; Pasquier C; Bonnet E; Aquilina C; Puel J; Massip P; Marchou B
J Med Virol; 1999 Feb; 57(2):163-8. PubMed ID: 9892402
[TBL] [Abstract][Full Text] [Related]
31. [AIDS: small, life-prolonging steps. Antiviral therapy is more efficient--a decrease in side effects].
Mahler W
Fortschr Med; 1989 Sep; 107(26):18-9. PubMed ID: 2553564
[No Abstract] [Full Text] [Related]
32. Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3.
Revicki DA; Swartz C; Wu AW; Haubrich R; Collier AC
Antivir Ther; 1999; 4(1):35-44. PubMed ID: 10682127
[TBL] [Abstract][Full Text] [Related]
33. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
[No Abstract] [Full Text] [Related]
34. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
[TBL] [Abstract][Full Text] [Related]
35. ddC (zalcitabine).
Skowron G
Adv Exp Med Biol; 1996; 394():257-69. PubMed ID: 8815690
[No Abstract] [Full Text] [Related]
36. [Anti-retroviral treatment. Treatment modification: toxicity management].
Ocaña I; Laguna F; Pulido F; Bascuñana A
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():31-5. PubMed ID: 9053025
[No Abstract] [Full Text] [Related]
37. More HIV patients may benefit from zalcitabine now.
RN; 1995 Jan; 58(1):66. PubMed ID: 7624706
[No Abstract] [Full Text] [Related]
38. [New AIDS drug: dideoxycytidine (DDC)].
Wien Med Wochenschr; 1992; 142(17):395. PubMed ID: 1336260
[No Abstract] [Full Text] [Related]
39. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
[No Abstract] [Full Text] [Related]
40. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
